Close

    NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP)  MAHARASHTRA STATE

    • Date : 17/04/2025 -

     NATIONAL LEPROSY ERADICATION PROGRAMME (NLEP)  MAHARASHTRA STATE

    Introduction : Since 1955 National Leprosy Control Programme was being implemented on SET pattern (Survey, Education and Treatment) through vertical Infrastructure. In 1981-82 MDT was introduced in the State in phase wise manner, covering all the districts by 1995-96. MDT has yielded wonderful results in the form of reduction of P.R. from 62.40/10,000 (3,12,877 Balance Leprosy Cases under treatment) in 1981-82 to 14.70/10,000 (1,18,864 Cases) by end of 1991-92. In 1981-82 national leprosy control programme renamed as a national leprosy eradication programme. The decline in PR continued and PR during 2001-02 was 3.27/10,000 (32,318 Balance Leprosy Cases under treatment) and PR 1.19/10,000 (15347 Balance  Leprosy  Cases under treatment)  by end of February 2025.

    NLEP is Centrally Sponsored programme. This programme is integrated in to General Health Care Service.  The NLEP is implemented in the State by Govt./ Local bodies (Zilla Parishad, Municipal Corporation and Municipal Councils) and Voluntary organizations. The State had achieved Leprosy elimination by end of Sep. 2005. (Elimination means to reduce the Prevalence Rate (PR) of the state less than 1 per 10000 populations)

    Organogram :

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Vision : Leprosy free India with zero infection and disease, zero disability, zero stigma and discrimination.

    Goal : Accelerate towards achieving Interruption of Leprosy Transmission in India.

    Specific objectives :

    • Strengthen leadership, commitment, and partnerships
    • Acceleration of Case Detection
    • Provision of Quality Services
    • Enhanced measures for Prevention of Disease, Disabilities, Stigma, Discrimination and Violation of Human Rights
    • Digitalization of Surveillance Systems

     

    Infrastructure  :

     

    Sr. No. Type of Institution Institutions
    1 Supervisory Urban Leprosy Units (SULU) 23
    2 Urban Leprosy Centers (ULC) 237
    3 Temporary Hospitalization Ward (Mumbai, Pune, Nagpur) 3
    4 Govt. Lep. Dispensaries/ Kushtadham (Bandorwala Leprosy Hospital Pune,  Shendapark Kolhapur) 2
    5 Reconstructive Surgery Units run by NGO 8
    6 Leprosy Training Centers Govt. (LTC –Pune, Nagpur) 2
    7 New NGO Scheme 2024-2025 5
    7.1 NGO 11
    7.2 Rehabilitation Services based NGO 16
    7.3 Hospitals Services based NGO 13

     

     

     

     

     

    Services rendered through NLEP:-

    • MDT (Multi Drug Therepy) :-
    1. After making a diagnosis of leprosy, one should group the patient based on certain characteristics. This is important because it help in selecting the correct combination of drug for given patient.
    • Paucibacillary
    • Multibacillary
    • Grouping is done depending on number of skin lesions, nerves and smear positivity as follows
    S.No Characteristic PB (Paucibacillary) MB (Multi bacillary)
    1 Skin lesions 1-5 lesions More than 5 lesions
    2 Peripheral nerve involvement No nerve/only one nerve with or without 1 to 5 lesions one or more nerve irrespective of number of skin lesions
    3 Skin smear Negative at all sites Positive at any site
    4 Treatment duration 6 months 12 months

     

    • The treatment of leprosy for both PB & MB is in the form multi drug therapy (MDT), which is the combination of three of the following drug.
    1. Rifampicin :-  10mg/kg body weight, monthly once
    2. Clofazimine  :-  1 mg/kg body weight daily and 6mg/kg body weight, monthly once
    3. Dapsone      :-  2mg/kg body weight daily

    Note :- Since 1st April 2025 the treatment regimen for PB is three drugs combination as of MB for the leprosy cases detected after 31st March 2025.

    • Disability Prevention & Medical Rehabilitation (DPMR)
    1. Two pairs/Year of MCR footwear free of cost are provided to eligible Leprosy patients to avoid ulcer.
    2. Goggles are supplied free of cost to eligible Leprosy patients of eye deformity.
    3. Splints are provided free of cost to Hand Deformity patients for not to develop further deformity.
    4. Ulcer Treatment are given free of cost to needy leprosy patients at PHCs, Dispensaries of Municipal Councils & Municipal Corporation, LRC and Self Settled Colonies.
    5. Physiotherapy Services are given free of cost to needy leprosy patients having deformity or not to develop deformity at all Govt. Hospitals, LRC and Self Settled Colonies.
    • RCS :-
    1. Reconstructive Surgeries are performed on eligible deformed patients at General Hospitals and selected NGOs free of costs.
    2. An incentive amounting to Rs.12,000/- is given to Leprosy Affected Persons for each Major Operation of Reconstructive Surgery (RCS).
    3. Medical Colleges and District Hospital are also paid Rs.5000/- for each of the Major RCS conducted.
    4. An incentive amounting to Rs.5,000/patient is given to those NGOs they performed more than 20 RCS.

    LRC ( Leprosy Referral Centre) :-

     

    • Total 277 LRCs established in Civil Hospitals/SDH/RH

    Main objectives of LRC are :-

    • To provide quality services, for diagnosis and management of leprosy and allied complications (lepra reaction & neuritis- disability threatening condition occurring during or after treatment) to persons affected leprosy.
    • To provide quality preventive services for prevention of disability among persons affected with leprosy having risk for nerve damage.
    • To provide quality care services for prevention of deterioration / worsening of deformity among persons affected leprosy living with disability.

     

    • IEC :- With the help of print media, electronics media & Social media following key messages given to society

     

    1. Sign & Symptoms of Leprosy
    2. Type of leprosy
    3. Stigma & discrimination
    4. Type of treatment & availability of treatment
    5. Treatment available at all Govt./Semi Govt. institute of free of cost
    6. Availability of DPMR services
    7. Benefits for volunteers, ASHA etc.

     

    A ) Print Media :- D )  Traditional Media :-
    1 Poster 1 Wall Paintings Rally
    2 Banner 2 Rally
    3 Pamphlets 3 Exhibition
    4 Diagnostic Cards 4 School Health Activity
    5 Flip Chart    
    B ) Electronic Media :- E) Other  Media :-
    1 Radio zingals 1 Bricks Kiln/Construction sites/Mazoor Adda

     

    • PEP (Post Exposure Prophylaxis) :-

     

    • Inclusion Criteria of PEP :-
    1. A person who has been living/working/having social activities for more than three months and 20 hours/week with a newly detected case of leprosy in a year.
    2. Age > 2 years.

     

    • Exclusion criteria of PEP :-
    1. Pregnant women (PEP can be given after delivery).
    2. People receiving Rifampicin for any reason in the last two years (e.g. for Tuberculosis (TB) or Leprosy or as a contact of index case of Leprosy).
    3. People who have possible signs and/or symptoms of leprosy.
    4. Person with acute febrile illness.
    5. People with a history of liver disorders (ask for H/o jaundice, right sided abdominal pain and swelling, swelling in legs and ankles, pale colored stool).
    6. People with a history of renal disorders (ask for H/o decreased urine output, swelling in legs and ankles, H/o high BP).
    7. People who have possible signs and/or symptoms of TB (Patients having any of the these symptoms should be screened for TB: cough for more than two week, night sweats, unexplained fever, weight loss).
    8. However, patients with signs and symptoms of other diseases including leprosy may be referred to nearest health facilities for further confirmation and management.

    Physical Performance last 5 years :

    S.N. Indicators 2019-20 2020-21 2021-22 2022-23 2023-24 2024-25 (up to Feb. 2025)
    1 New cases detected (NCD) 16531 12438 14520 19860 20001 18860
    ANCDR/ lakh* 13.07 9.55 11.14 15.58 15.54 15.36
    2 Total Active Cases 10203 10417 11607 13088 14976 15347
    P.R./10,000 0.81 0.8 0.89 1.03 1.16 1.19
    3 Child Cases among NCD 1360 922 1092 1301 1321 1015
    % of Child Cases among NCD 8.23 7.41 7.52 6.55 6.60 5.38
    4 Gr.II Deformity Cases among NCD 258 160 141 184 138 118
    % Gr.II Deformity Cases among NCD 1.56 1.29 0.97 0.93 0.69 0.63
    Gr.II Deformity Cases per Million Population 2.04 1.23 1.08 1.44 1.07 0.92

    * The ANCDR/Lakh rate has been calculated based on the number of new leprosy cases detected during last 12-month period from March 2024 to February 2025.

     

    Leprosy Case Detection Campaign :-

    This campaign started from 2015-16. In this activity with the help of ASHA and male volunteers, a door-to-door survey was conducted in 100 % rural areas and about 30 percent of the high-risk urban areas. This activity created a large-scale awareness about leprosy and succeeded in finding the hidden leprosy patients in the society in early stage and bringing them under MDT treatment. In the year 2024-25, this campaign was implemented in 20 high-risk districts of the state from 31st January to 15th February 2025 and in this campaign, 3826 new leprosy patients were detected and all of them were started on MDT treatment.

    Year wise NCD cases in LCDC :-

    Sr. No Year LCDC cases Total cases District Involved
    1 2015-16 166 15695 5
    2 2016-17 4134 15012 16
    3 2017-18 5073 16065 22
    4 2018-19 5268 15299 35
    5 2019-20 6116 16531 35
    6 2022-23 6731 19860 35
    7 2023-24 6744 20001 35
    8 2024-25 (up to Feb.2025) 3826 18860 20

     

    Innovative activity – KuSuM  

    Introduction of KuSuM :-

    1. Government of India has given a clarion call to achieve zero leprosy transmission by 2027,three years ahead of SDG
    2. To achieve zero leprosy transmission state need to first detect all hidden leprosy cases in the entire community
    3. Active leprosy case detection need to be focused on marginalized groups viz brick kiln sites , migratory people, construction sites, residential schools for physically/mentally challenged students ,night shelters, mines , other industrial workers etc.
    4. Most of the times marginalized groups go to work early in the morning and return home late in the evening and because of that they miss routine health check up and LCDC also
    5. Right now there is no special activity for early detection of leprosy cases

    from marginalized groups

    1. Mapping of marginalized groups is completed
    2. Screening of marginalized groups

    Daily reporting, analysis of the data and feedback

    • KuSuM (Kushthmukta Surakshit Maharashtra) 2023-24
    SN High Risk Areas Total No No of Enumeration Physical examination % Suspects  identified Suspect Examined % Total confirmed cases Total G2D cases in NCD
    MB PB Total
    1 Bricking sites     7460 224453 212984 95 2766 2766 100 128 230 358 1
    2 Ashram School   1971 519029 476060 92 2847 2834 100 18 140 158 0
    3 Migrated people  16164 406471 332064 82 2005 2003 100 55 80 135 2
    4 Ashram School Hostel  983 180880 162683 85 779 779 100 4 47 51 0
    5 Prisons 49 39333 35726 91 206 202 98 16 33 49 0
    6 Mines  908 60910 57176 94 361 361 100 11 13 24 0
    7 Other high risk places  3193 148103 126359 85 512 512 100 44 30 74 0
    Maharashtra 30728 1579179 1403052 89 9476 9457 99.7 276 573 (67.5%) 849 3
    • KuSuM (Kushthmukta Surakshit Maharashtra) 2024-25
    SN High Risk Areas Total No No of Enumeration Physical examination % Suspects  identified Suspect Examined % Total confirmed cases Total G2D cases in NCD
    MB PB Total
    1 Bricking sites     7303 261525 256402 98.0 5907 5836 98.8 96 195 291 0
    2  Ashram School   1999 580643 570704 98.3 9369 9268 98.9 16 117 133 0
    3 Migrated people  22050 600188 579157 96.5 7879 7650 97.1 133 200 333 2
    4 Ashram School Hostel  1245 232119 207940 89.6 3241 3186 98.3 10 36 46 0
    5 Prisons 49 40103 31713 79.1 368 368 100 13 31 44 0
    6 Mines  964 55713 51570 92.6 1060 1060 100 8 17 25 0
    7 Other high risk places  1375 201639 200477 99.4 3969 3880 97.8 59 91 150 0
    Maharashtra 34985 1971930 1897963 96.2 31793 31248 98.3 335 687 (67.2) 1022 2

     

    Beneficiary:

    Citizens

    Benefits:

    As above

    How To Apply

    Online